inspection – Page 251

Inadequate worst-case justification during inspection readiness – CAPA and revalidation failure

Understanding Inadequate Worst-Case Justification and Its Implications for Inspection Readiness In pharmaceutical manufacturing, ensuring compliance with Good Manufacturing Practices (GMP) is critical to maintaining product quality and regulatory approval. A…

Requalification overdue during requalification – CAPA and revalidation failure

Addressing Requalification Failures in Pharmaceutical Manufacturing: A Case Study In a recent scenario at a pharmaceutical manufacturing facility, the Quality Assurance (QA) team discovered that critical equipment requalification was overdue…

Validation protocol deviation ignored during requalification – regulatory deficiency case study

Case Study: Regulatory Noncompliance Following an Ignored Validation Protocol Deviation The pharmaceutical manufacturing sector is rife with regulations to ensure product quality and patient safety. However, even the most robust…

Process validation not repeated after change during requalification – CAPA and revalidation failure

Understanding the Failures of Process Validation During Change and Requalification In the pharmaceutical manufacturing landscape, maintaining compliance with Good Manufacturing Practices (GMP) is crucial for product quality and regulatory adherence.…

Requalification overdue during inspection readiness – regulatory deficiency case study

Investigating Requalification Delays: A Case Study on Regulatory Compliance Deficiencies The pharmaceutical industry operates under stringent regulations, where adherence to Good Manufacturing Practices (GMP) is paramount. An inspection readiness scenario…

Process validation not repeated after change during inspection readiness – regulatory deficiency case study

Case Study: The Implications of Failing to Repeat Process Validation After Changes in Manufacturing In the complex landscape of pharmaceutical manufacturing, ensuring compliance with regulatory standards is paramount. A recent…

Requalification overdue during requalification – inspection outcome explained

Case Study: Addressing Requalification Delays During the Validation Process In the highly regulated pharmaceutical industry, maintaining compliance with Good Manufacturing Practices (GMP) is paramount. A recent case of a requalification…

Process validation not repeated after change during validation lifecycle – regulatory deficiency case study

Case Study on Regulatory Deficiency Due to Unrepeated Process Validation After Changes In pharmaceutical manufacturing, the importance of adhering to Good Manufacturing Practices (GMP) is paramount. A common issue arises…

PPQ acceptance criteria changed post hoc during change control – inspection outcome explained

Understanding the Inspection Outcomes of Changed PPQ Acceptance Criteria During Change Control In the highly regulated pharmaceutical industry, changes to established processes can trigger significant compliance challenges, particularly when PPQ…

Validation protocol deviation ignored during change control – regulatory deficiency case study

Case Study: Addressing Ignored Validation Protocol Deviation in Change Control In the highly regulated pharmaceutical manufacturing environment, compliance with validation protocols is critical not only for product quality but also…

Process validation not repeated after change during validation lifecycle – inspection outcome explained

Case Study on Incomplete Process Validation After Change During the Validation Lifecycle In a large biopharmaceutical facility, a significant compliance issue arose regarding the validation of a manufacturing process for…

CSV not aligned with actual use during change control – inspection outcome explained

Addressing the Non-Alignment of CSV with Actual Use During Change Control in Pharma In the complex world of pharmaceutical manufacturing, adherence to Good Manufacturing Practices (GMP) is paramount. A case…